Search - tctmd.com

Displaying 101 - 119 of 119

Sort: Relevancy | Date

News Daily News

Some New-Generation Stents Prone to Longitudinal Distortion

November 29, 2011

News Conference News

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

L.A. McKeown

November 28, 2011

News Conference News

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

November 27, 2011

News Conference News

RIBS III: Alternative DES Best Bet for DES In-Stent Restenosis

November 22, 2011

News Conference News

Stent Thrombosis Linked to Uncovered, Malapposed Stent Struts

November 21, 2011

News Conference News

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

November 20, 2011

News Industry News

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

November 13, 2011

News Industry News

Elixir Medical Corporation Announces Successful Completion of First-In-Man Study Enrollment for Fully Bioresorbable Drug Eluting Coronary Scaffold System

November 02, 2011

News Daily News

TRIAS HR Published: Genous Stent Doubles Target Lesion Failure

Leah Lawrence

August 23, 2011

News Daily News

ESSENCE-DIABETES Published: Xience, Cypher Equally Equipped to Treat Diabetics

Caitlin E. Cox

August 03, 2011

News Daily News

ISAR-TEST 5 Published: Polymer-Free Dual DES Noninferior to Resolute

Jason Kahn

July 21, 2011

News Daily News

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Jason Kahn

June 13, 2011

News Daily News

Predictors of Adverse Events in Pulmonary Artery Intervention Identified

L.A. McKeown

May 06, 2011

News Daily News

Two-Year Data Published from SPIRIT IV, COMPARE: Xience Still Favored Over Taxus

April 20, 2011

News Conference News

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

Caitlin E. Cox

April 08, 2011

News Daily News

Cilostazol Reduces Repeat Revascularizations for Long Lesions

March 06, 2011

News Daily News

Zilver PTX: Novel DES for Femoropopliteal Disease Encouraging at 2 Years

January 17, 2011

News Daily News

PES Show Delayed Healing in STEMI Patients, Clinical Significance Downplayed

Jason Kahn

January 12, 2011

News Daily News

Final Kissing Balloon Unnecessary in Single-Stent Approach to Bifurcation Lesions

Caitlin E. Cox

January 04, 2011

Advertisement

Some New-Generation Stents Prone to Longitudinal Distortion

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

RIBS III: Alternative DES Best Bet for DES In-Stent Restenosis

Stent Thrombosis Linked to Uncovered, Malapposed Stent Struts

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

Elixir Medical Corporation Announces Successful Completion of First-In-Man Study Enrollment for Fully Bioresorbable Drug Eluting Coronary Scaffold System

TRIAS HR Published: Genous Stent Doubles Target Lesion Failure

ESSENCE-DIABETES Published: Xience, Cypher Equally Equipped to Treat Diabetics

ISAR-TEST 5 Published: Polymer-Free Dual DES Noninferior to Resolute

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Predictors of Adverse Events in Pulmonary Artery Intervention Identified

Two-Year Data Published from SPIRIT IV, COMPARE: Xience Still Favored Over Taxus

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

Cilostazol Reduces Repeat Revascularizations for Long Lesions

Zilver PTX: Novel DES for Femoropopliteal Disease Encouraging at 2 Years

PES Show Delayed Healing in STEMI Patients, Clinical Significance Downplayed

Final Kissing Balloon Unnecessary in Single-Stent Approach to Bifurcation Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content